Literature DB >> 12458396

14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.

Teemu O Takala1, Pirjo Nuutila, Kari Pulkki, Vesa Oikonen, Tove Grönroos, Timo Savunen, Tommi Vähäsilta, Matti Luotolahti, Markku Kallajoki, Jörgen Bergman, Sarita Forsback, Juhani Knuuti.   

Abstract

14( R, S)-[(18)F]Fluoro-6-thia-heptadecanoic acid ([(18)F]FTHA) is a long-chain fatty acid substrate for fatty acid metabolism. [(18)F]FTHA has been used to study fatty acid metabolism in human heart and skeletal muscle. It has been suggested that the rate of radioactivity accumulation in the myocardium reflects the beta-oxidation rate of free fatty acids (FFAs). However, the net accumulation of FFAs in tissue always represents the sum of FFA oxidation and incorporation into triglycerides. The fraction of [(18)F]FTHA entering directly into mitochondria for oxidation has not been previously measured. Eight anaesthetized pigs were studied with [(18)F]FTHA and positron emission tomography (PET). Immediately after each PET experiment, tissue samples from myocardium and skeletal muscle were taken for the isolation of mitochondria and measurements of radioactivity accumulation, and for intracellular [(18)F]FTHA metabolite analysis. Fractional [(18)F]FTHA uptake rates were calculated both by graphical analysis of PET data and by measuring (18)F in the tissue samples. Fractional [(18)F]FTHA uptake rates based on the analysis of tissue samples were 0.56+/-0.17 ml g(-1) min(-1) and 0.037+/-0.007 ml g(-1) min(-1) for myocardium and skeletal muscle (mean +/- SD), respectively. The myocardial results obtained from the PET data (0.50+/-0.11 ml g(-1) min(-1)) were similar to the values obtained from the tissue samples ( r=0.94, P=0.002). We also found that 89%+/-23% (mean+/-SD, n=7) of the (18)F entered mitochondria in myocardium, as compared with only 36%+/-15% (mean+/-SD, n=7) in skeletal muscle. Intracellular [(18)F]FTHA metabolite analysis showed that a major part of [(18)F]FTHA is metabolized in the mitochondria in the heart. Our data suggest that ~89% of [(18)F]FTHA taken up by the heart enters mitochondria. This supports the hypothesis that [(18)F]FTHA traces FFA beta-oxidation in the heart. In contrast to this, only ~36% of [(18)F]FTHA accumulated in skeletal muscle appears to directly enter mitochondria; the majority is taken up by the other cell fractions, suggesting that in skeletal muscle [(18)F]FTHA traces FFA uptake but not specifically FFA beta-oxidation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458396     DOI: 10.1007/s00259-002-0979-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  Noninvasive evaluation of fat-carbohydrate metabolic switching in heart and contracting skeletal muscle.

Authors:  Timothy R DeGrado; Mukesh K Pandey; Anthony P Belanger; Falguni Basuli; Aditya Bansal; Shuyan Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-04       Impact factor: 4.310

2.  Clinical cardiac PET in the future.

Authors:  Juhani Knuuti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

3.  Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.

Authors:  Zhude Tu; Shihong Li; Terry L Sharp; Pilar Herrero; Carmen S Dence; Robert J Gropler; Robert H Mach
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

4.  The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats.

Authors:  Xiuli Ci; Frédérique Frisch; François Lavoie; Pascale Germain; Roger Lecomte; Johan E van Lier; François Bénard; André C Carpentier
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

5.  Determination of Fatty Acid Metabolism with Dynamic [11C]Palmitate Positron Emission Tomography of Mouse Heart In Vivo.

Authors:  Yinlin Li; Tao Huang; Xinyue Zhang; Min Zhong; Natalie N Walker; Jiang He; Stuart S Berr; Susanna R Keller; Bijoy K Kundu
Journal:  Mol Imaging       Date:  2015       Impact factor: 4.488

6.  Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins.

Authors:  Jarna C Hannukainen; Pirjo Nuutila; Ronald Borra; Borra Ronald; Jaakko Kaprio; Urho M Kujala; Tuula Janatuinen; Olli J Heinonen; Jukka Kapanen; Tapio Viljanen; Merja Haaparanta; Tapani Rönnemaa; Riitta Parkkola; Juhani Knuuti; Kari K Kalliokoski
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

Review 7.  Metabolic imaging using PET.

Authors:  Takashi Kudo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05-05       Impact factor: 9.236

8.  Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats.

Authors:  Sébastien L Ménard; Xiuli Ci; Frédérique Frisch; François Normand-Lauzière; Jules Cadorette; René Ouellet; Johannes E Van Lier; François Bénard; M'hamed Bentourkia; Roger Lecomte; André C Carpentier
Journal:  Mol Imaging Biol       Date:  2008-09-04       Impact factor: 3.488

Review 9.  Myocardial fatty acid metabolism and cardiac performance in heart failure.

Authors:  Helena Tuunanen; Heikki Ukkonen; Juhani Knuuti
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

10.  Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension.

Authors:  Katarzyna Drozd; Ali Ahmadi; Yupu Deng; Baohua Jiang; Julia Petryk; Stephanie Thorn; Duncan Stewart; Rob Beanlands; Robert A deKemp; Jean N DaSilva; Lisa M Mielniczuk
Journal:  J Nucl Cardiol       Date:  2016-09-29       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.